{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:48:15Z","timestamp":1790970495051,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJ9-166217, PJT-169116"],"award-info":[{"award-number":["PJ9-166217, PJT-169116"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["NSERC; RGPIN-2019-05204"],"award-info":[{"award-number":["NSERC; RGPIN-2019-05204"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["16890"],"award-info":[{"award-number":["16890"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pre-clinical and cell culture evidence supports the role of the ketone beta-hydroxybutyrate (BHB) as an immunomodulatory molecule that may inhibit inflammatory signalling involved in several chronic diseases such as type 2 diabetes (T2D), but studies in humans are lacking. Therefore, we investigated the anti-inflammatory effect of BHB in humans across three clinical trials. To investigate if BHB suppressed pro-inflammatory cytokine secretion, we treated LPS-stimulated leukocytes from overnight-fasted adults at risk for T2D with BHB (Study 1). Next (Study 2), we investigated if exogenously raising BHB acutely in vivo by ketone monoester supplementation (KME) in adults with T2D would suppress pro-inflammatory plasma cytokines. In Study 3, we investigated the effect of BHB on inflammation via ex vivo treatment of LPS-stimulated leukocytes with BHB and in vivo thrice-daily pre-meal KME for 14 days in adults with T2D. Ex vivo treatment with BHB suppressed LPS-stimulated IL-1\u03b2, TNF-\u03b1, and IL-6 secretion and increased IL-1RA and IL-10 (Study 1). Plasma IL-10 increased by 90 min following ingestion of a single dose of KME in T2D, which corresponded to peak blood BHB (Study 2). Finally, 14 days of thrice-daily KME ingestion did not significantly alter plasma cytokines or leukocyte subsets including monocyte and T-cell polarization (Study 3). However, direct treatment of leukocytes with BHB modulated TNF-\u03b1, IL-1\u03b2, IFN-\u03b3, and MCP-1 secretion in a time- and glucose-dependent manner (Study 3). Therefore, BHB appears to be anti-inflammatory in T2D, but this effect is transient and is modulated by the presence of disease, glycaemia, and exposure time.<\/jats:p>","DOI":"10.1093\/cei\/uxad138","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T01:02:05Z","timestamp":1704848525000},"page":"89-103","source":"Crossref","is-referenced-by-count":22,"title":["Effect of the ketone beta-hydroxybutyrate on markers of inflammation and immune function in adults with type 2 diabetes"],"prefix":"10.1093","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8051-1542","authenticated-orcid":false,"given":"Helena","family":"Neudorf","sequence":"first","affiliation":[{"name":"University of British Columbia Okanagan, School of Health and Exercise Sciences , Kelowna, BC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim","family":"Islam","sequence":"additional","affiliation":[{"name":"University of British Columbia Okanagan, School of Health and Exercise Sciences , Kelowna, BC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3240-964X","authenticated-orcid":false,"given":"Kaja","family":"Falkenhain","sequence":"additional","affiliation":[{"name":"University of British Columbia Okanagan, School of Health and Exercise Sciences , Kelowna, BC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Oliveira","sequence":"additional","affiliation":[{"name":"University of British Columbia Okanagan, School of Health and Exercise Sciences , Kelowna, BC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garett S","family":"Jackson","sequence":"additional","affiliation":[{"name":"University of British Columbia Okanagan, School of Health and Exercise Sciences , Kelowna, BC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Moreno-Caba\u00f1as","sequence":"additional","affiliation":[{"name":"University of Castilla-La Mancha, Department of Sport Sciences, Exercise Physiology Lab at Toledo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Madden","sequence":"additional","affiliation":[{"name":"University of British Columbia, Department of Medicine, Centre of Aging SMART , Vancouver, BC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Singer","sequence":"additional","affiliation":[{"name":"University of British Columbia, School of Population and Public Health , Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J","family":"Walsh","sequence":"additional","affiliation":[{"name":"McMaster University, Department of Kinesiology , Hamilton, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P","family":"Little","sequence":"additional","affiliation":[{"name":"University of British Columbia Okanagan, School of Health and Exercise Sciences , Kelowna, BC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"2024031215042366100_CIT0001","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology, and application of monitoring diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"2024031215042366100_CIT0002","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"\u03b2-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep"},{"key":"2024031215042366100_CIT0003","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","article-title":"Beta-hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology","volume":"17","author":"Shippy","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2024031215042366100_CIT0004","doi-asserted-by":"crossref","first-page":"109451","DOI":"10.1016\/j.intimp.2022.109451","article-title":"Beta-hydroxybutyrate alleviates pyroptosis in MPP+\/MPTP-induced Parkinson\u2019s disease models via inhibiting STAT3\/NLRP3\/GSDMD pathway","volume":"113","author":"Jiang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"2024031215042366100_CIT0005","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1210\/clinem\/dgaa925","article-title":"14-Day ketone supplementation lowers glucose and improves vascular function in obesity: a randomized crossover trial","volume":"106","author":"Walsh","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024031215042366100_CIT0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"2024031215042366100_CIT0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"2024031215042366100_CIT0008","doi-asserted-by":"crossref","first-page":"66444","DOI":"10.18632\/oncotarget.12119","article-title":"\u03b2-hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation","volume":"7","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"key":"2024031215042366100_CIT0009","doi-asserted-by":"crossref","first-page":"777","DOI":"10.14336\/AD.2019.0926","article-title":"\u03b2-hydroxybutyrate suppresses lipid accumulation in aged liver through GPR109A-mediated signaling","volume":"11","author":"Lee","year":"2020","journal-title":"Aging Dis"},{"key":"2024031215042366100_CIT0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"2024031215042366100_CIT0011","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00125-006-0570-3","article-title":"Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome","volume":"50","author":"Benfield","year":"2007","journal-title":"Diabetologia"},{"key":"2024031215042366100_CIT0012","doi-asserted-by":"crossref","first-page":"e000181","DOI":"10.1136\/bmjdrc-2015-000181","article-title":"Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients","volume":"4","author":"Martins","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2024031215042366100_CIT0013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"2024031215042366100_CIT0014","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI113991","article-title":"Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat: evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia","volume":"83","author":"Feingold","year":"1989","journal-title":"JCI"},{"key":"2024031215042366100_CIT0015","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"2024031215042366100_CIT0016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-[beta] links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"key":"2024031215042366100_CIT0017","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"2024031215042366100_CIT0018","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00296-018-4041-1","article-title":"Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis","volume":"38","author":"Nikfar","year":"2018","journal-title":"Rheumatol Int"},{"key":"2024031215042366100_CIT0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"2024031215042366100_CIT0020","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra therapy for non-cancer inflammatory diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024031215042366100_CIT0021","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2337\/dc12-1835","article-title":"Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1\u03b2 antibody, in patients with type 2 diabetes","volume":"36","author":"Sloan-Lancaster","year":"2013","journal-title":"Diabetes Care"},{"key":"2024031215042366100_CIT0022","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Anti-inflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2024031215042366100_CIT0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1113\/EP090430","article-title":"Exogenous ketone supplementation: an emerging tool for physiologists with potential as a metabolic therapy","volume":"108","author":"Falkenhain","year":"2023","journal-title":"Exp Physiol"},{"key":"2024031215042366100_CIT0024","doi-asserted-by":"crossref","first-page":"e1801171-n\/a","DOI":"10.1002\/mnfr.201801171","article-title":"Oral ketone supplementation acutely increases markers of NLRP3 inflammasome activation in human monocytes","volume":"63","author":"Neudorf","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"2024031215042366100_CIT0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ajcn\/nqy170","article-title":"Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies","volume":"108","author":"Thomsen","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"2024031215042366100_CIT0026","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2174\/1381612826666200203120540","article-title":"Potential therapeutic effects of exogenous ketone supplementation for type 2 diabetes: a review","volume":"26","author":"Walsh","year":"2020","journal-title":"Curr Pharm Des"},{"key":"2024031215042366100_CIT0027","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1152\/ajpendo.00332.2023","article-title":"The effect of acute and 14-day exogenous ketone supplementation on glycaemic control in adults with type 2 diabetes: two randomized controlled trials","volume":"326","author":"Falkenhain","year":"2023","journal-title":"Am J Physiol Endo Metab"},{"key":"2024031215042366100_CIT0028","doi-asserted-by":"crossref","first-page":"21244","DOI":"10.1038\/srep21244","article-title":"Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes","volume":"6","author":"Barry","year":"2016","journal-title":"Sci Rep"},{"key":"2024031215042366100_CIT0029","doi-asserted-by":"crossref","first-page":"C1095","DOI":"10.1152\/ajpcell.00091.2022","article-title":"Sex differences in IL-10\u2019s anti-inflammatory function: greater STAT3 activation and stronger inhibition of TNF-\u03b1 production in male blood leukocytes ex vivo","volume":"322","author":"Islam","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"2024031215042366100_CIT0030","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.febslet.2013.05.053","article-title":"High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation","volume":"587","author":"Joshi","year":"2013","journal-title":"FEBS Lett"},{"key":"2024031215042366100_CIT0031","doi-asserted-by":"crossref","first-page":"165940","DOI":"10.1016\/j.bbadis.2020.165940","article-title":"Glucose induces metabolic reprogramming in neutrophils during type 2 diabetes to form constitutive extracellular traps and decreased responsiveness to lipopolysaccharides","volume":"1866","author":"Joshi","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2024031215042366100_CIT0032","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00134-002-1628-4","article-title":"High glucose impairs superoxide production from isolated blood neutrophils","volume":"29","author":"Perner","year":"2003","journal-title":"Intensive Care Med"},{"key":"2024031215042366100_CIT0033","doi-asserted-by":"crossref","first-page":"e92977","DOI":"10.1371\/journal.pone.0092977","article-title":"Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia","volume":"9","author":"Restrepo","year":"2014","journal-title":"PLoS One"},{"key":"2024031215042366100_CIT0034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1479-5876-10-35","article-title":"Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus","volume":"10","author":"Hair","year":"2012","journal-title":"J Transl Med"},{"key":"2024031215042366100_CIT0035","doi-asserted-by":"crossref","first-page":"762051","DOI":"10.1155\/2014\/762051","article-title":"Hyperglycemia inhibits complement-mediated immunological control of s. aureus in a rat model of peritonitis","volume":"2014","author":"Mauriello","year":"2014","journal-title":"J Diabetes Res"},{"key":"2024031215042366100_CIT0036","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1084\/jem.178.6.2207","article-title":"Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes Evidence for an autocrine role of tumor necrosis factor and IL-1\u03b2 in mediating the production of IL-8 triggered by lipopolysaccharide","volume":"178","author":"Cassatella","year":"1993","journal-title":"J Exp Med"},{"key":"2024031215042366100_CIT0037","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/08820139909061145","article-title":"Interleukin 10 inhibits TNF-alpha production in human monocytes independently of interleukin 12 and interleukin 1 beta","volume":"28","author":"Shin","year":"1999","journal-title":"Immunol Invest"},{"key":"2024031215042366100_CIT0038","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphys.2017.00848","article-title":"On the metabolism of exogenous ketones in humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front Physiol"},{"key":"2024031215042366100_CIT0039","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/advances\/nmac036","article-title":"Effects of exogenous ketone supplementation on blood glucose: a systematic review and meta-analysis","volume":"13","author":"Falkenhain","year":"2022","journal-title":"Adv Nutr"},{"key":"2024031215042366100_CIT0040","doi-asserted-by":"crossref","first-page":"104506","DOI":"10.1016\/j.yrtph.2019.104506","article-title":"Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults","volume":"109","author":"Soto-Mota","year":"2019","journal-title":"Regul Toxicol Pharmacol"},{"key":"2024031215042366100_CIT0041","doi-asserted-by":"crossref","first-page":"e00264-n\/a","DOI":"10.1002\/edm2.264","article-title":"Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control","volume":"4","author":"Soto-Mota","year":"2021","journal-title":"Endocrinol Diabetes Metab J"},{"key":"2024031215042366100_CIT0042","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1113\/JP275709","article-title":"Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals","volume":"596","author":"Myette-C\u00f4t\u00e9","year":"2018","journal-title":"J Physiol"},{"key":"2024031215042366100_CIT0043","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/ajcn\/nqz232","article-title":"A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial","volume":"110","author":"Myette-C\u00f4t\u00e9","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"2024031215042366100_CIT0044","author":"L\u00fcdecke","year":"2023"},{"key":"2024031215042366100_CIT0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"2024031215042366100_CIT0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmertest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J Stat Softw"},{"key":"2024031215042366100_CIT0047","volume-title":"Estimated Marginal Means, aka Least-Squares Means","author":"Lenth","year":"2021"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxad138\/56346165\/uxad138.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/216\/1\/89\/56947415\/uxad138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/216\/1\/89\/56947415\/uxad138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T19:37:17Z","timestamp":1710272237000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/216\/1\/89\/7513429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,9]]},"published-print":{"date-parts":[[2024,3,12]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxad138","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,1,9]]}}}